Literature DB >> 23430122

Approval of a tuberculosis drug based on a paradoxical surrogate measure.

Jerry Avorn1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430122     DOI: 10.1001/jama.2013.623

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  18 in total

1.  Recent advances in tuberculosis: New drugs and treatment regimens.

Authors:  Derek J Sloan; Geraint R Davies; Saye H Khoo
Journal:  Curr Respir Med Rev       Date:  2013-06-01

2.  First use of bedaquiline in a patient with XDR-TB in Singapore.

Authors:  Angeline Poh-Gek Chua; Grace Si-Ru Hoo; Cynthia Bin-Eng Chee; Yee Tang Wang
Journal:  BMJ Case Rep       Date:  2015-09-23

3.  Drug-resistant tuberculosis: a new shot on goal.

Authors:  Carl Nathan
Journal:  Nat Med       Date:  2014-02       Impact factor: 53.440

4.  2-(Quinolin-4-yloxy)acetamides Are Active against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains.

Authors:  Kenia Pissinate; Anne Drumond Villela; Valnês Rodrigues-Junior; Bruno Couto Giacobbo; Estêvão Silveira Grams; Bruno Lopes Abbadi; Rogério Valim Trindade; Laura Roesler Nery; Carla Denise Bonan; Davi Fernando Back; Maria Martha Campos; Luiz Augusto Basso; Diógenes Santiago Santos; Pablo Machado
Journal:  ACS Med Chem Lett       Date:  2016-01-11       Impact factor: 4.345

Review 5.  Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?

Authors:  Stephen K Field
Journal:  Ther Adv Chronic Dis       Date:  2015-07       Impact factor: 5.091

Review 6.  Individual and composite study endpoints: separating the wheat from the chaff.

Authors:  Robert Goldberg; Joel M Gore; Bruce Barton; Jerry Gurwitz
Journal:  Am J Med       Date:  2014-01-28       Impact factor: 4.965

7.  Antitubercular Activity of Novel 2-(Quinoline-4-yloxy)acetamides with Improved Drug-Like Properties.

Authors:  Ana Flávia Borsoi; Laura Manzoli Alice; Nathalia Sperotto; Alessandro Silva Ramos; Bruno Lopes Abbadi; Fernanda Souza Macchi Hopf; Adilio da Silva Dadda; Raoní S Rambo; Rodrigo Braccini Madeira Silva; Josiane Delgado Paz; Kenia Pissinate; Mauro Neves Muniz; Christiano Ev Neves; Luiza Galina; Laura Calle González; Marcia Alberton Perelló; Alexia de Matos Czeczot; Mariana Leyser; Sílvia Dias de Oliveira; Graziela de Araújo Lock; Bibiana Verlindo de Araújo; Teresa Dalla Costa; Cristiano Valim Bizarro; Luiz Augusto Basso; Pablo Machado
Journal:  ACS Med Chem Lett       Date:  2022-07-21       Impact factor: 4.632

8.  Outcome Assessments in Clinical Trials of Cryptococcal Meningitis: Considerations on Use of Early Fungicidal Activity as a Potential Surrogate Endpoint for All-Cause Mortality.

Authors:  Jairo Mauricio Montezuma-Rusca; John H Powers
Journal:  Curr Treat Options Infect Dis       Date:  2014-07-29

9.  Whole-cell screening-based identification of inhibitors against the intraphagosomal survival of Mycobacterium tuberculosis.

Authors:  Garima Khare; Praveen Kumar; Anil K Tyagi
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

10.  Salts and Polymorph Screens for Bedaquiline.

Authors:  Mercy Okezue; Susan Bogdanowich-Knipp; Daniel Smith; Matthias Zeller; Stephen Byrn; Pamela Smith; Dale K Purcell; Kari Clase
Journal:  AAPS PharmSciTech       Date:  2021-08-25       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.